(Q35779946)

10 August 2017

title

A mutation in the interferon regulatory element of HBV may influence the response of interferon treatment in chronic hepatitis B patients (English)

1 reference

10 August 2017

1 reference

1 reference

Jia-Jie Lu

1

1 reference

10 August 2017

En-Qiang Chen

2

1 reference

10 August 2017

Jia-Hong Yang

3

1 reference

10 August 2017

Tao-You Zhou

4

1 reference

10 August 2017

Li Liu

5

1 reference

10 August 2017

Hong Tang

6

1 reference

10 August 2017

publication date

10 January 2012

1 reference

10 August 2017

1 reference

10 August 2017

volume

9

1 reference

10 August 2017

page(s)

10

1 reference

Chronic hepatitis B: update 2009

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3287143

Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3287143

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3287143

In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3287143

Inhibition of Alpha Interferon Signaling by Hepatitis B Virus

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3287143

Expression of ICAM-1, HLA-DR, and CD80 on peripheral circulating CD1 alpha DCs induced in vivo by IFN-alpha in patients with chronic hepatitis B

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3287143

In vitro resistance to interferon of hepatitis B virus with precore mutation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3287143

Global epidemiology of hepatitis B virus

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3287143

Treatment with interferons (including pegylated interferons) in patients with hepatitis B.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3287143

Transcriptional and posttranscriptional control of hepatitis B virus gene expression

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3287143

Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3287143

Functional characterization of the interferon regulatory element in the enhancer 1 region of the hepatitis B virus genome

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3287143

IRF family of transcription factors as regulators of host defense

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3287143

p48 (ISGF-3gamma) is involved in interferon-alpha-induced suppression of hepatitis B virus enhancer-1 activity

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3287143

Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3287143

Preliminary identification and analysis of point mutations correlated with response to interferon-alpha in hepatitis B virus post-transcriptional regulatory elements.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3287143

Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3287143

Long-term remission of chronic hepatitis B after alpha-interferon therapy

15 November 2018

1 reference

12 December 2020

Recombinant interferon alfa-2b following prednisone withdrawal in the treatment of chronic type B hepatitis

1 reference

12 December 2020

Hepatic histologic and immunohistochemical changes in chronic hepatitis B after prolonged clearance of hepatitis B e antigen and hepatitis B surface antigen

1 reference

12 December 2020

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

12 December 2020

A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B

1 reference

12 December 2020

Identifiers

DOI

10.1186/1743-422X-9-10

1 reference

10 August 2017

1 reference

10 August 2017

1 reference